| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_821a6739093a95150d2980c6da6a2d3b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-09 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-2458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-242
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-24 |
| filingDate |
2013-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a9560c56a982dd4cf264505253d434b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_287d45c7719727daf26bbc7d8742e56a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b0516e42ce57a814b545b09286fbebc |
| publicationDate |
2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112014026817-A2 |
| titleOfInvention |
pantothenate derivatives for the treatment of neurological disorders |
| abstract |
Abstract "pantothenate derivatives for the treatment of neurological disorders" The present invention relates to pantothenate derivatives for the treatment of neurological disorders (such as pantothenate kinase-associated neurodegeneration), pharmaceutical compositions containing such compounds and their use in the treatment of neurological disorders. r (amino acid) r 'r' 'me (l-ala) me me (l-aia) et bn me (l-ala) mecypr mecypr melndol (l-trp) bn et |
| priorityDate |
2012-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |